aluates Reports

$ 0.0

Automative

Global Hematology Oncology Diagnostics Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-18W12541

Global Hematology Oncology Diagnostics Market Research Report 2022

BUY CHAPTERS

Global Hematology Oncology Diagnostics Market Research Report 2024

Code: QYRE-Auto-18W12541

Report

April 2024

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott Laboratories

Roche

Qiagen NV

Thermo Fisher Scientific

Illumina Inc

Bio Rad

Archerdx

ARUP Laboratories

Asuragen

Invivoscribe

Adaptive Biotechnologies

Amoy Diagnostics

ELITechGroup

Vela Diagnostics

Gentronix Limited

Bioivt

Berry Genomics

SAGA Diagnostics

Hematology Oncology Diagnostics Market Size

The global Hematology Oncology Diagnostics market was valued at US$ 2572.8 million in 2023 and is anticipated to reach US$ 4366.3 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.

Hematology Oncology Diagnostics Market

Physicians use a variety of tests to accurately diagnose cancer, determine prognosis, and monitor cancer for progression and side effects.

The Hematology Oncology Diagnostics market has seen substantial growth due to increasing cancer prevalence, advancements in diagnostic technologies, and a growing emphasis on early disease detection.

This report aims to provide a comprehensive presentation of the global market for Hematology Oncology Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Oncology Diagnostics.

Report Scope

The Hematology Oncology Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematology Oncology Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hematology Oncology Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hematology Oncology Diagnostics Market Report

Report Metric	Details
Report Name	Hematology Oncology Diagnostics Market
Accounted market size in 2023	US$ 2572.8 million
Forecasted market size in 2030	US$ 4366.3 million
CAGR	8.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	PCR IHC NGS Cytogenetics Others
Segment by Application	Clinical Laboratories Hospitals Research Institutes Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Roche, QIAGEN, Thermo Fisher Scientific, Illumina, Bio-Rad, ArcherDX, ARUP Laboratories, Asuragen, Invivoscribe, Adaptive Biotechnologies, Amoy Diagnostics, ELITechGroup, Vela Diagnostics, Gentronix, BioIVT, SAGA Diagnostics, Berry Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematology Oncology Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hematology Oncology Diagnostics Market growing?

Ans: The Hematology Oncology Diagnostics Market witnessing a CAGR of 8.1% during the forecast period 2024-2030.

What is the Hematology Oncology Diagnostics Market size in 2030?

Ans: The Hematology Oncology Diagnostics Market size in 2030 will be US$ 4366.3 million.

Who are the main players in the Hematology Oncology Diagnostics Market report?

Ans: The main players in the Hematology Oncology Diagnostics Market are Abbott Laboratories, Roche, QIAGEN, Thermo Fisher Scientific, Illumina, Bio-Rad, ArcherDX, ARUP Laboratories, Asuragen, Invivoscribe, Adaptive Biotechnologies, Amoy Diagnostics, ELITechGroup, Vela Diagnostics, Gentronix, BioIVT, SAGA Diagnostics, Berry Genomics

What are the Application segmentation covered in the Hematology Oncology Diagnostics Market report?

Ans: The Applications covered in the Hematology Oncology Diagnostics Market report are Clinical Laboratories, Hospitals, Research Institutes, Other

What are the Type segmentation covered in the Hematology Oncology Diagnostics Market report?

Ans: The Types covered in the Hematology Oncology Diagnostics Market report are PCR, IHC, NGS, Cytogenetics, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hematology Oncology Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 PCR

1.2.3 IHC

1.2.4 NGS

1.2.5 Cytogenetics

1.2.6 Others

1.3 Market by Application

1.3.1 Global Hematology Oncology Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Laboratories

1.3.3 Hospitals

1.3.4 Research Institutes

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hematology Oncology Diagnostics Market Perspective (2019-2030)

2.2 Hematology Oncology Diagnostics Growth Trends by Region

2.2.1 Global Hematology Oncology Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Hematology Oncology Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Hematology Oncology Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Hematology Oncology Diagnostics Market Dynamics

2.3.1 Hematology Oncology Diagnostics Industry Trends

2.3.2 Hematology Oncology Diagnostics Market Drivers

2.3.3 Hematology Oncology Diagnostics Market Challenges

2.3.4 Hematology Oncology Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hematology Oncology Diagnostics Players by Revenue

3.1.1 Global Top Hematology Oncology Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Hematology Oncology Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Hematology Oncology Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Hematology Oncology Diagnostics Revenue

3.4 Global Hematology Oncology Diagnostics Market Concentration Ratio

3.4.1 Global Hematology Oncology Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hematology Oncology Diagnostics Revenue in 2023

3.5 Hematology Oncology Diagnostics Key Players Head office and Area Served

3.6 Key Players Hematology Oncology Diagnostics Product Solution and Service

3.7 Date of Enter into Hematology Oncology Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Hematology Oncology Diagnostics Breakdown Data by Type

4.1 Global Hematology Oncology Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Hematology Oncology Diagnostics Forecasted Market Size by Type (2025-2030)

5 Hematology Oncology Diagnostics Breakdown Data by Application

5.1 Global Hematology Oncology Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Hematology Oncology Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hematology Oncology Diagnostics Market Size (2019-2030)

6.2 North America Hematology Oncology Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Hematology Oncology Diagnostics Market Size by Country (2019-2024)

6.4 North America Hematology Oncology Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hematology Oncology Diagnostics Market Size (2019-2030)

7.2 Europe Hematology Oncology Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Hematology Oncology Diagnostics Market Size by Country (2019-2024)

7.4 Europe Hematology Oncology Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hematology Oncology Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Hematology Oncology Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Hematology Oncology Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Hematology Oncology Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hematology Oncology Diagnostics Market Size (2019-2030)

9.2 Latin America Hematology Oncology Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Hematology Oncology Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Hematology Oncology Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hematology Oncology Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Hematology Oncology Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Hematology Oncology Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Hematology Oncology Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Hematology Oncology Diagnostics Introduction

11.1.4 Abbott Laboratories Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.1.5 Abbott Laboratories Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Hematology Oncology Diagnostics Introduction

11.2.4 Roche Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.2.5 Roche Recent Development

11.3 QIAGEN

11.3.1 QIAGEN Company Detail

11.3.2 QIAGEN Business Overview

11.3.3 QIAGEN Hematology Oncology Diagnostics Introduction

11.3.4 QIAGEN Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.3.5 QIAGEN Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Detail

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Hematology Oncology Diagnostics Introduction

11.4.4 Thermo Fisher Scientific Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Illumina

11.5.1 Illumina Company Detail

11.5.2 Illumina Business Overview

11.5.3 Illumina Hematology Oncology Diagnostics Introduction

11.5.4 Illumina Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.5.5 Illumina Recent Development

11.6 Bio-Rad

11.6.1 Bio-Rad Company Detail

11.6.2 Bio-Rad Business Overview

11.6.3 Bio-Rad Hematology Oncology Diagnostics Introduction

11.6.4 Bio-Rad Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.6.5 Bio-Rad Recent Development

11.7 ArcherDX

11.7.1 ArcherDX Company Detail

11.7.2 ArcherDX Business Overview

11.7.3 ArcherDX Hematology Oncology Diagnostics Introduction

11.7.4 ArcherDX Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.7.5 ArcherDX Recent Development

11.8 ARUP Laboratories

11.8.1 ARUP Laboratories Company Detail

11.8.2 ARUP Laboratories Business Overview

11.8.3 ARUP Laboratories Hematology Oncology Diagnostics Introduction

11.8.4 ARUP Laboratories Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.8.5 ARUP Laboratories Recent Development

11.9 Asuragen

11.9.1 Asuragen Company Detail

11.9.2 Asuragen Business Overview

11.9.3 Asuragen Hematology Oncology Diagnostics Introduction

11.9.4 Asuragen Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.9.5 Asuragen Recent Development

11.10 Invivoscribe

11.10.1 Invivoscribe Company Detail

11.10.2 Invivoscribe Business Overview

11.10.3 Invivoscribe Hematology Oncology Diagnostics Introduction

11.10.4 Invivoscribe Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.10.5 Invivoscribe Recent Development

11.11 Adaptive Biotechnologies

11.11.1 Adaptive Biotechnologies Company Detail

11.11.2 Adaptive Biotechnologies Business Overview

11.11.3 Adaptive Biotechnologies Hematology Oncology Diagnostics Introduction

11.11.4 Adaptive Biotechnologies Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.11.5 Adaptive Biotechnologies Recent Development

11.12 Amoy Diagnostics

11.12.1 Amoy Diagnostics Company Detail

11.12.2 Amoy Diagnostics Business Overview

11.12.3 Amoy Diagnostics Hematology Oncology Diagnostics Introduction

11.12.4 Amoy Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.12.5 Amoy Diagnostics Recent Development

11.13 ELITechGroup

11.13.1 ELITechGroup Company Detail

11.13.2 ELITechGroup Business Overview

11.13.3 ELITechGroup Hematology Oncology Diagnostics Introduction

11.13.4 ELITechGroup Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.13.5 ELITechGroup Recent Development

11.14 Vela Diagnostics

11.14.1 Vela Diagnostics Company Detail

11.14.2 Vela Diagnostics Business Overview

11.14.3 Vela Diagnostics Hematology Oncology Diagnostics Introduction

11.14.4 Vela Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.14.5 Vela Diagnostics Recent Development

11.15 Gentronix

11.15.1 Gentronix Company Detail

11.15.2 Gentronix Business Overview

11.15.3 Gentronix Hematology Oncology Diagnostics Introduction

11.15.4 Gentronix Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.15.5 Gentronix Recent Development

11.16 BioIVT

11.16.1 BioIVT Company Detail

11.16.2 BioIVT Business Overview

11.16.3 BioIVT Hematology Oncology Diagnostics Introduction

11.16.4 BioIVT Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.16.5 BioIVT Recent Development

11.17 SAGA Diagnostics

11.17.1 SAGA Diagnostics Company Detail

11.17.2 SAGA Diagnostics Business Overview

11.17.3 SAGA Diagnostics Hematology Oncology Diagnostics Introduction

11.17.4 SAGA Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.17.5 SAGA Diagnostics Recent Development

11.18 Berry Genomics

11.18.1 Berry Genomics Company Detail

11.18.2 Berry Genomics Business Overview

11.18.3 Berry Genomics Hematology Oncology Diagnostics Introduction

11.18.4 Berry Genomics Revenue in Hematology Oncology Diagnostics Business (2019-2024)

11.18.5 Berry Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott Laboratories

Roche

Qiagen NV

Thermo Fisher Scientific

Illumina Inc

Bio Rad

Archerdx

ARUP Laboratories

Asuragen

Invivoscribe

Adaptive Biotechnologies

Amoy Diagnostics

ELITechGroup

Vela Diagnostics

Gentronix Limited

Bioivt

Berry Genomics

SAGA Diagnostics

List of Tables

Table 1. Global Hematology Oncology Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of PCR

Table 3. Key Players of IHC

Table 4. Key Players of NGS

Table 5. Key Players of Cytogenetics

Table 6. Key Players of Others

Table 7. Global Hematology Oncology Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Hematology Oncology Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Hematology Oncology Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Hematology Oncology Diagnostics Market Share by Region (2019-2024)

Table 11. Global Hematology Oncology Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Hematology Oncology Diagnostics Market Share by Region (2025-2030)

Table 13. Hematology Oncology Diagnostics Market Trends

Table 14. Hematology Oncology Diagnostics Market Drivers

Table 15. Hematology Oncology Diagnostics Market Challenges

Table 16. Hematology Oncology Diagnostics Market Restraints

Table 17. Global Hematology Oncology Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Hematology Oncology Diagnostics Market Share by Players (2019-2024)

Table 19. Global Top Hematology Oncology Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematology Oncology Diagnostics as of 2023)

Table 20. Ranking of Global Top Hematology Oncology Diagnostics Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Hematology Oncology Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Hematology Oncology Diagnostics Product Solution and Service

Table 24. Date of Enter into Hematology Oncology Diagnostics Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Hematology Oncology Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Hematology Oncology Diagnostics Revenue Market Share by Type (2019-2024)

Table 28. Global Hematology Oncology Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Hematology Oncology Diagnostics Revenue Market Share by Type (2025-2030)

Table 30. Global Hematology Oncology Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Hematology Oncology Diagnostics Revenue Market Share by Application (2019-2024)

Table 32. Global Hematology Oncology Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Hematology Oncology Diagnostics Revenue Market Share by Application (2025-2030)

Table 34. North America Hematology Oncology Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Hematology Oncology Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Hematology Oncology Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Hematology Oncology Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Hematology Oncology Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Hematology Oncology Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Hematology Oncology Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Hematology Oncology Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Hematology Oncology Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Hematology Oncology Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Hematology Oncology Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Hematology Oncology Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Hematology Oncology Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Hematology Oncology Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Hematology Oncology Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 49. Abbott Laboratories Company Detail

Table 50. Abbott Laboratories Business Overview

Table 51. Abbott Laboratories Hematology Oncology Diagnostics Product

Table 52. Abbott Laboratories Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 53. Abbott Laboratories Recent Development

Table 54. Roche Company Detail

Table 55. Roche Business Overview

Table 56. Roche Hematology Oncology Diagnostics Product

Table 57. Roche Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 58. Roche Recent Development

Table 59. QIAGEN Company Detail

Table 60. QIAGEN Business Overview

Table 61. QIAGEN Hematology Oncology Diagnostics Product

Table 62. QIAGEN Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 63. QIAGEN Recent Development

Table 64. Thermo Fisher Scientific Company Detail

Table 65. Thermo Fisher Scientific Business Overview

Table 66. Thermo Fisher Scientific Hematology Oncology Diagnostics Product

Table 67. Thermo Fisher Scientific Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 68. Thermo Fisher Scientific Recent Development

Table 69. Illumina Company Detail

Table 70. Illumina Business Overview

Table 71. Illumina Hematology Oncology Diagnostics Product

Table 72. Illumina Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 73. Illumina Recent Development

Table 74. Bio-Rad Company Detail

Table 75. Bio-Rad Business Overview

Table 76. Bio-Rad Hematology Oncology Diagnostics Product

Table 77. Bio-Rad Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 78. Bio-Rad Recent Development

Table 79. ArcherDX Company Detail

Table 80. ArcherDX Business Overview

Table 81. ArcherDX Hematology Oncology Diagnostics Product

Table 82. ArcherDX Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 83. ArcherDX Recent Development

Table 84. ARUP Laboratories Company Detail

Table 85. ARUP Laboratories Business Overview

Table 86. ARUP Laboratories Hematology Oncology Diagnostics Product

Table 87. ARUP Laboratories Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 88. ARUP Laboratories Recent Development

Table 89. Asuragen Company Detail

Table 90. Asuragen Business Overview

Table 91. Asuragen Hematology Oncology Diagnostics Product

Table 92. Asuragen Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 93. Asuragen Recent Development

Table 94. Invivoscribe Company Detail

Table 95. Invivoscribe Business Overview

Table 96. Invivoscribe Hematology Oncology Diagnostics Product

Table 97. Invivoscribe Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 98. Invivoscribe Recent Development

Table 99. Adaptive Biotechnologies Company Detail

Table 100. Adaptive Biotechnologies Business Overview

Table 101. Adaptive Biotechnologies Hematology Oncology Diagnostics Product

Table 102. Adaptive Biotechnologies Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 103. Adaptive Biotechnologies Recent Development

Table 104. Amoy Diagnostics Company Detail

Table 105. Amoy Diagnostics Business Overview

Table 106. Amoy Diagnostics Hematology Oncology Diagnostics Product

Table 107. Amoy Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 108. Amoy Diagnostics Recent Development

Table 109. ELITechGroup Company Detail

Table 110. ELITechGroup Business Overview

Table 111. ELITechGroup Hematology Oncology Diagnostics Product

Table 112. ELITechGroup Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 113. ELITechGroup Recent Development

Table 114. Vela Diagnostics Company Detail

Table 115. Vela Diagnostics Business Overview

Table 116. Vela Diagnostics Hematology Oncology Diagnostics Product

Table 117. Vela Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 118. Vela Diagnostics Recent Development

Table 119. Gentronix Company Detail

Table 120. Gentronix Business Overview

Table 121. Gentronix Hematology Oncology Diagnostics Product

Table 122. Gentronix Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 123. Gentronix Recent Development

Table 124. BioIVT Company Detail

Table 125. BioIVT Business Overview

Table 126. BioIVT Hematology Oncology Diagnostics Product

Table 127. BioIVT Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 128. BioIVT Recent Development

Table 129. SAGA Diagnostics Company Detail

Table 130. SAGA Diagnostics Business Overview

Table 131. SAGA Diagnostics Hematology Oncology Diagnostics Product

Table 132. SAGA Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 133. SAGA Diagnostics Recent Development

Table 134. Berry Genomics Company Detail

Table 135. Berry Genomics Business Overview

Table 136. Berry Genomics Hematology Oncology Diagnostics Product

Table 137. Berry Genomics Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)

Table 138. Berry Genomics Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hematology Oncology Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Hematology Oncology Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. PCR Features

Figure 4. IHC Features

Figure 5. NGS Features

Figure 6. Cytogenetics Features

Figure 7. Others Features

Figure 8. Global Hematology Oncology Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Hematology Oncology Diagnostics Market Share by Application: 2023 VS 2030

Figure 10. Clinical Laboratories Case Studies

Figure 11. Hospitals Case Studies

Figure 12. Research Institutes Case Studies

Figure 13. Other Case Studies

Figure 14. Hematology Oncology Diagnostics Report Years Considered

Figure 15. Global Hematology Oncology Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Hematology Oncology Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Hematology Oncology Diagnostics Market Share by Region: 2023 VS 2030

Figure 18. Global Hematology Oncology Diagnostics Market Share by Players in 2023

Figure 19. Global Top Hematology Oncology Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematology Oncology Diagnostics as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Hematology Oncology Diagnostics Revenue in 2023

Figure 21. North America Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Hematology Oncology Diagnostics Market Share by Country (2019-2030)

Figure 23. United States Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Hematology Oncology Diagnostics Market Share by Country (2019-2030)

Figure 27. Germany Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Hematology Oncology Diagnostics Market Share by Region (2019-2030)

Figure 35. China Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Hematology Oncology Diagnostics Market Share by Country (2019-2030)

Figure 43. Mexico Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Hematology Oncology Diagnostics Market Share by Country (2019-2030)

Figure 47. Turkey Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Abbott Laboratories Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 50. Roche Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 51. QIAGEN Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 53. Illumina Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 54. Bio-Rad Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 55. ArcherDX Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 56. ARUP Laboratories Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 57. Asuragen Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 58. Invivoscribe Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 59. Adaptive Biotechnologies Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 60. Amoy Diagnostics Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 61. ELITechGroup Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 62. Vela Diagnostics Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 63. Gentronix Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 64. BioIVT Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 65. SAGA Diagnostics Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 66. Berry Genomics Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Blood Cancer Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematology Testing Product Market Research Report 2024

Global Haemato Oncology Testing Market Research Report 2025

Hematologic Malignancies Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematology Controls Market Research Report 2025

Global Tumor Marker Testing Market Research Report 2024

Global Hematology Device Market Insights Forecast to 2030

Global Hematology Instrument Market Insights Forecast to 2030

Oncology Blood Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematologic Malignancies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Precision Cancer Tests Market Research Report 2024

Global Hematology Diagnostic Device Market Research Report 2024

Global Epigenetics Diagnostic Market Insights Forecast to 2030

Hematology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Laboratory Test Market Research Report 2024

Global Oncology Companion Diagnostic Market Research Report 2024

Precision Cancer Diagnostic Tests Market

Hematology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematology Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions